Search

everythinglearnresearchcommunity

for

Search:↓

About 2.2% of women with symptoms of high male hormones have a mild form of congenital adrenal hyperplasia, and measuring a specific hormone level can accurately diagnose it.

High levels of TNF-α may contribute to obesity and insulin resistance in PCOS, but not due to the C850T genetic variation.

Chromosomal differences affect how muscle cells respond to testosterone.

A new gene mutation may cause cyclic thrombocytopenia by affecting platelet production.

Shorter GGN repeats in the androgen receptor gene are linked to androgenetic alopecia.

Finasteride and dutasteride's effects are mainly due to target binding saturation and slow enzyme turnover.

Antiretrovirals can affect finasteride's effectiveness, so dose adjustments may be needed for men on HIV treatment.

Different types of PPARγ are found in varying amounts in human skin and its parts, which could affect how skin treatments work.

PDE5 inhibitors cause earlier adverse events in BPH treatment, requiring careful monitoring.

Two types of finasteride tablets work the same in the body.

The document concludes that PCOS has a strong genetic component, but more research is needed to fully understand the specific genes involved.

The method accurately measures finasteride in plasma and is suitable for clinical use.

Genetic changes in specific proteins contribute to hair loss in some women of African descent.

The document concludes that proper diagnosis and a multidisciplinary approach are crucial for managing Congenital Adrenal Hyperplasia effectively.

Finasteride irreversibly affects human steroid 5α-reductase 2, providing insight into its catalytic mechanism and disease-related mutations.

There is no significant link between the MMP-1 rs1799750 polymorphism and androgenetic alopecia in the Indonesian population.

A new genetic variant in the EEF2K gene may contribute to polycystic ovary syndrome.

Lignans and neolignans from plants may help protect against various health issues, including cancer and heart disease.

Cannabinoids may help treat chronic and chemotherapy-induced neuropathic pain, but more research is needed to confirm their effectiveness and safety.

Dutasteride effectively treats enlarged prostate, reduces prostate cancer risk, and promotes hair regrowth with few side effects.

Finasteride has a higher risk of reproductive side effects than minoxidil.

Progestogens are essential in menopausal hormone therapy to prevent uterine cancer and must be chosen carefully based on individual needs.

Treating epilepsy is complex, requiring careful drug choice and patient adherence to manage seizures and side effects.

Aromatase inhibitors can cause skin issues, especially with anastrozole and exemestane, so monitoring is important.

Dutasteride is effective for treating prostate enlargement and reducing related surgery risk, but is not approved for preventing prostate cancer.

Elderly skin care needs personalized treatment, early intervention, and integrated psychiatric care.

New methods for measuring dutasteride are effective and reliable.

Pharmacists play a crucial role in improving treatment outcomes and staying updated on various health conditions.

Dutasteride is more effective than finasteride for hair loss treatment.

Terbinafine is the most effective medicine for fungal nail infections, especially for diabetics and those with weak immune systems.